Annovis Bio Inc
NYSE:ANVS
Income Statement
Earnings Waterfall
Annovis Bio Inc
Income Statement
Annovis Bio Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(6)
|
(7)
|
(9)
|
(9)
|
(11)
|
(15)
|
(17)
|
(20)
|
(24)
|
(26)
|
(26)
|
(29)
|
(38)
|
(45)
|
(43)
|
(41)
|
(30)
|
(27)
|
(25)
|
(24)
|
(27)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(6)
|
(8)
|
(10)
|
(10)
|
(9)
|
(8)
|
(8)
|
(6)
|
(6)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
(13)
|
(17)
|
(18)
|
(22)
|
(31)
|
(39)
|
(38)
|
(35)
|
(24)
|
(20)
|
(18)
|
(18)
|
(21)
|
|
| Operating Income |
(1)
N/A
|
(1)
-1%
|
(1)
-13%
|
(1)
-12%
|
(2)
-77%
|
(2)
-25%
|
(4)
-111%
|
(6)
-32%
|
(7)
-18%
|
(9)
-40%
|
(9)
+0%
|
(11)
-13%
|
(15)
-38%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(26)
-8%
|
(26)
0%
|
(29)
-15%
|
(38)
-29%
|
(45)
-19%
|
(43)
+5%
|
(41)
+5%
|
(30)
+26%
|
(27)
+12%
|
(25)
+6%
|
(24)
+6%
|
(27)
-13%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
(5)
|
(1)
|
(1)
|
0
|
5
|
1
|
1
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
0
|
(1)
|
(10)
|
2
|
(8)
|
(7)
|
1
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-1%
|
(1)
-17%
|
(1)
-13%
|
(1)
-4%
|
(1)
-24%
|
(3)
-160%
|
(4)
-24%
|
(5)
-38%
|
(8)
-51%
|
(8)
-3%
|
(10)
-22%
|
(14)
-41%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(25)
-8%
|
(25)
+1%
|
(29)
-14%
|
(37)
-29%
|
(56)
-52%
|
(48)
+15%
|
(43)
+10%
|
(41)
+5%
|
(25)
+40%
|
(29)
-18%
|
(30)
-4%
|
(25)
+18%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(4)
|
(5)
|
(8)
|
(8)
|
(10)
|
(14)
|
(17)
|
(20)
|
(24)
|
(25)
|
(25)
|
(29)
|
(37)
|
(56)
|
(48)
|
(43)
|
(41)
|
(25)
|
(29)
|
(30)
|
(25)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-1%
|
(1)
-17%
|
(1)
-13%
|
(1)
-4%
|
(1)
-24%
|
(3)
-160%
|
(4)
-24%
|
(5)
-38%
|
(8)
-51%
|
(8)
-3%
|
(10)
-22%
|
(14)
-41%
|
(17)
-14%
|
(20)
-21%
|
(24)
-18%
|
(25)
-8%
|
(25)
+1%
|
(29)
-14%
|
(37)
-29%
|
(56)
-52%
|
(48)
+15%
|
(43)
+10%
|
(41)
+5%
|
(25)
+40%
|
(29)
-18%
|
(30)
-4%
|
(25)
+18%
|
|
| EPS (Diluted) |
-0.12
N/A
|
-0.12
N/A
|
-0.14
-17%
|
-0.16
-14%
|
-0.14
+12%
|
-0.26
-86%
|
-0.46
-77%
|
-0.57
-24%
|
-0.87
-53%
|
-1.2
-38%
|
-1.14
+5%
|
-1.26
-11%
|
-1.9
-51%
|
-2.02
-6%
|
-2.45
-21%
|
-2.89
-18%
|
-3.1
-7%
|
-3.09
+0%
|
-3.21
-4%
|
-4.11
-28%
|
-6.23
-52%
|
-4.47
+28%
|
-3.8
+15%
|
-3.15
+17%
|
-2.02
+36%
|
-1.66
+18%
|
-1.55
+7%
|
-1.26
+19%
|
|